05.12.26 -- Transendocardial Cell Delivery In Post‑Acute Myocardial Infarction

AI is transforming cell therapy manufacturing and enabling more personalized treatments. Explore how to navigate innovation in a fast-moving therapeutic landscape with actionable insights.

Tube welding and biosafety cabinets present significant costs and risks for small-volume aseptic processing. Modern single-use aseptic connectors offer a more efficient alternative.

Scaling LNP production requires precise control over turbulent mixing and lipid science. Review the essential parameters needed to maintain formulation integrity during the upscaling process.

Standardized, modular production simplifies line integration and reduces engineering overhead. Uncover how flexible manufacturing models enable faster changeovers and improved facility agility.

Get a clear, data-driven look at the biggest pressure points in cell therapy manufacturing. Survey the latest trends shaping today’s production challenges and where new opportunities are emerging.

A streamlined workflow reduces reagent use and hands‑on time while preserving long‑read sequencing quality. See how multiplexed offer an efficient option for scaling or mobilizing sequencing efforts.

Learn how to implement a validated, broad-spectrum qPCR workflow that covers over 250 species, ensuring both regulatory compliance and accelerated speed-to-market for your clinical-grade products.

From HEK293 scalability limitations to freeze-thaw degradation and bag breakage losses, examine five underestimated challenges that routinely derail viral vector manufacturing at scale.

Accurate, readable pharmaceutical labels are crucial. Navigate considerations like printing, application tolerances, and inspection to select the right machinery for your production environment.

Distinguishing between viruses and viral vectors is key to biosafety. Understand how effective disinfection solutions protect patients and maintain the integrity of pharmaceutical manufacturing.

With USP <665> now official as of May 1, 2026, proactive preparation is essential to ensure compliance and prevent delays, regulatory observations, or supply chain disruptions.